Life Science Leadership Series – Oncology 12 May 2011 Clare College, Cambridge To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
Astex Therapeutics today announced that it had begun dosing first patients in a Phase I/IIa clinical trial of its investigational anti-cancer drug AT9283. More
Astex Therapeutics today announced a new drug discovery collaboration which will aim to identify small molecule inhibitors of the Fibroblast Growth Factor Receptor (FGFr) tyrosine kinase family. More